Fhj. Van Enckevort et al., Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice, J ENDOC INV, 24(10), 2001, pp. 786-795
Administration of bacterial lipopolysaccharide (LPS) in rodents induces the
release of pro-inflammatory cytokines [tumor necrosis factor (TNF), interl
eukin (IL)-1, IL-6] and of ACTH and corticosterone. IL-6 is probably an imp
ortant cytokine in the interaction between the immune system and the hypoth
alamus-pituitary-adrenal (HPA) axis, but so far the role of IL-6 in lipopol
ysaccharide (LPS)-induced HPA activation has not been established unequivoc
ally. We examined the effects of intraperitoneal administration of LPS (ran
ge 0.25-2000 mug/mouse) on plasma corticosterone, TNF alpha and IL-1 alpha
levels in IL-6-deficient (IL-6 -/-) and wildtype control (IL-6 +/+) mice. P
lasma corticosterone levels increased within one hour in both mouse strains
. The corticosterone response was significantly reduced in IL-6 -/- mice, b
ut no differences in TNF alpha or in IL-1 alpha plasma levels were found be
tween the two strains. Next, we studied the involvement of IL-1 alpha or TN
F alpha in the responses to LIPS in IL-6 -/- and IL-6 +/+ mice by infusion
of recombinant human IL-1 receptor antagonist (IL-1 alpha), or by injection
of anti-TNF alpha antibodies. Pretreatment with IL-1 alpha or with anti-TN
F alpha did not affect the corticosterone response to LPS, neither in IL-6
-/-, nor in IL-6 +/+ mice. Our data suggest that in the stimulation of the
HPA axis by LPS in mice blockade of either IL-1 alpha or TNF alpha may be c
ompensated for by other mediators. The reduced adrenal response after LPS a
dministration found in IL-6 -/- mice indicates a distinct role for IL-6 in
the activation of the HPA axis by LIPS. (C) 2001, Editrice Kurtis.